(Q34267681)

1 August 2017

Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease (English)

1 reference

1 August 2017

1 reference

Kristoffer Haugarvoll

6

object named as

Kristoffer Haugarvoll

1 reference

1 August 2017

8

Mathias Toft

1 reference

1 August 2017

18

Owen A Ross

1 reference

1 August 2017

9

John G Nutt

1 reference

1 August 2017

Carles Vilariño-Güell

2

object named as

Carles Vilariño-Güell

1 reference

1 August 2017

11

Jennifer M Kachergus

1 reference

1 August 2017

Jan O Aasly

1

1 reference

1 August 2017

Justus C Dachsel

3

1 reference

1 August 2017

Philip J Webber

4

1 reference

1 August 2017

Andrew B West

5

1 reference

1 August 2017

Krisztina K Johansen

7

1 reference

1 August 2017

Haydeh Payami

10

1 reference

1 August 2017

Sarah J Lincoln

12

1 reference

1 August 2017

Amela Felic

13

1 reference

1 August 2017

Christian Wider

14

1 reference

1 August 2017

Alexandra I Soto-Ortolaza

15

1 reference

1 August 2017

Stephanie A Cobb

16

1 reference

1 August 2017

Linda R White

17

1 reference

1 August 2017

Matthew J Farrer

19

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

1 August 2017

1 reference

1 August 2017

25

1 reference

1 August 2017

2156-2163

1 reference

1 August 2017

13

1 reference

describes a project that uses

1 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2970614/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Genomic investigation of alpha-synuclein multiplication and parkinsonism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Epidemiology of Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

LRRK2 in Parkinson's disease: protein domains and functional insights

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Genetics of Parkinson disease: paradigm shifts and future prospects.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Diagnostic criteria for Parkinson disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Parkinsonism: onset, progression, and mortality

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Lrrk2 and Lewy body disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Clinical features of LRRK2-associated Parkinson's disease in central Norway

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

Lrrk2 pathogenic substitutions in Parkinson's disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970614

28 October 2018

Identifiers

DOI

10.1002/MDS.23265

1 reference

1 August 2017

1 reference

1 August 2017

1 reference